Science Explorer Back to mapMap
Discussion
Topic · Rheumatology

Glycogen Storage Diseases and Myoclonus

Glycogen Storage Diseases and Myoclonus is a research topic within Rheumatology. Science Explorer counts 17k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the metabolism of glycogen, particularly in the context of myoclonic disorders such as progressive myoclonus epilepsy and glycogen storage diseases. It explores genetic mutations, neurodegeneration, and the role of the glucose-6-phosphatase system in these conditions, shedding light on diagnosis, management, and potential therapeutic aspects.

  • Glycogen
  • Metabolism
  • Myoclonic Disorders
  • Glycogen Storage Diseases
  • Lafora Disease
  • Glucose-6-Phosphatase System
  • Neurodegeneration
  • Epilepsy
  • Neutrophil Dysfunction
  • Genetic Mutations
Research works
17k
fractional, since 1950
In the world top 10%
1.7k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+15%
the tick is no change
Largest producer
United States
33% of the 10 largest, 2022-now
Glycogen Storage Diseases and Myoclonus

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Glycogen Storage Diseases and Myoclonus research?

By volume, the United States and China publish the most (672 and 288 works in 2022-now).

By volume, 2022-now

  1. 1 United States 672 works
  2. 2 China 288 works
  3. 3 India 192 works
  4. 4 Italy 182 works
  5. 5 Japan 154 works
  6. 6 United Kingdom 118 works
  7. 7 Germany 114 works
  8. 8 Brazil 113 works
  9. 9 France 106 works
  10. 10 Spain 102 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 32.9%China: 14.1%India: 9.4%Italy: 8.9%6 others listed: 34.6%33%largest
United States672 · 32.9%China288 · 14.1%India192 · 9.4%Italy182 · 8.9%6 others listed707 · 34.6%

Shares of the rows listed above, not of the whole node.

Which institutions lead Glycogen Storage Diseases and Myoclonus research?

By volume in 2022-now, University College London publishes the most Glycogen Storage Diseases and Myoclonus research, followed by Mayo Clinic and National Institutes of Health.

By volume, 2022-now

  1. 1 University College LondonUnited Kingdom 22 works
  2. 2 Mayo ClinicUnited States 22 works
  3. 3 National Institutes of HealthUnited States 20 works
  4. 4 All India Institute of Medical SciencesIndia 18 works
  5. 5 Harvard UniversityUnited States 17 works
  6. 6 InsermFrance 15 works
  7. 7 The University of Texas Southwestern Medical CenterUnited States 15 works
  8. 8 University of GroningenNetherlands 15 works
  9. 9 Duke UniversityUnited States 14 works
  10. 10 Zhejiang UniversityChina 14 works

Who are the leading researchers in Glycogen Storage Diseases and Myoclonus?

The most-cited researchers publishing on Glycogen Storage Diseases and Myoclonus include Gregory Y.H. Lip and John Q. Trojanowski.

  1. 1 Gregory Y.H. Lip United Kingdom 311k citations
  2. 2 John Q. Trojanowski United States 286k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Glycogen Storage Diseases and Myoclonus?

The most cited paper in Glycogen Storage Diseases and Myoclonus is "Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia" (Hartmut Döhner, Stephan Stilgenbauer, Axel Benner et al., 2000), with 3,318 citations. Next come "Creatine and Creatinine Metabolism" (2,964) and "Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease" (2,179).

Most cited papers
#PaperReleasedCitations
1 Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia Hartmut Döhner, Stephan Stilgenbauer, Axel Benner et al. · New England Journal of Medicine 28 Dec 2000 3,318
2 Creatine and Creatinine Metabolism Markus Wyss, Rima F Kaddurah-Daouk · Physiological Reviews Review Jul 2000 2,964
3 Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease E. Sidransky et al. · New England Journal of Medicine Open access 21 Oct 2009 2,179
4 Consensus Statement of the Movement Disorder Society on Tremor Günther Deuschl, Peter G. Bain, Mitchell F. Brin · Movement Disorders 20 Oct 2008 1,995
5 Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society Kailash P. Bhatia, Peter G. Bain, Nin P.S. Bajaj et al. · Movement Disorders Open access 30 Nov 2017 1,591
All 100 most cited papers, with filters and sorting

Where is Glycogen Storage Diseases and Myoclonus research done?

The largest centres of Glycogen Storage Diseases and Myoclonus research in 2022-now are Beijing (China), London (United Kingdom), Paris (France) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Durham and Bethesda.

Largest cities, 2022-now

  1. 1 BeijingChina 48 works
  2. 2 LondonUnited Kingdom 48 works
  3. 3 ParisFrance 44 works
  4. 4 TokyoJapan 40 works
  5. 5 MadridSpain 34 works
  6. 6 New YorkUnited States 31 works
  7. 7 São PauloBrazil 31 works
  8. 8 RomeItaly 29 works
  9. 9 IstanbulTürkiye 26 works
  10. 10 BengaluruIndia 26 works

Where it is the local speciality

  1. DurhamUS · 24.4 works7.2×
  2. BethesdaUS · 20.7 works6.0×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Glycogen Storage Diseases and Myoclonus than the world average.

See Glycogen Storage Diseases and Myoclonus on the map

Where is the best place to study Glycogen Storage Diseases and Myoclonus?

Among universities, judged by research, University of Groningen, University College London and University of Naples Federico II score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 18.16%fractional works in this field (log) →share of work in the world top 10% →University of Naples…University of Gronin…Erasmus University R…University College L…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1University of GroningenNetherlands 85.021.6%8.8×15 +28.5%
2University College LondonUnited Kingdom 81.517.4%5.6×22 -9.4%
3University of Naples Federico IIItaly 71.126.2%5.8×11 +84.8%
4Erasmus University RotterdamNetherlands 69.120.3%8.9×12 +6.0%
5Harvard UniversityUnited States 64.713.0%2.1×17 -0.6%
6Peking UniversityChina 59.024.4%2.1×11 +65.8%
7Duke UniversityUnited States 58.914.9%6.7×14 -13.8%
8Columbia UniversityUnited States 50.321.3%3.0×8 -16.1%
9University of FloridaUnited States 49.410.1%4.4×12 +47.8%
10Zhejiang UniversityChina 48.712.4%2.0×14 +87.4%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Glycogen Storage Diseases and Myoclonus, country by country

Is Glycogen Storage Diseases and Myoclonus research growing?

Output in 2022-2025 was 15% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Glycogen Storage Diseases and Myoclonus.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Glycogen Storage Diseases and Myoclonus as a percentage of every work published that year, 0.011% in 2024.

still counting0.020%0.040%Glycogen Storage Diseases and Myoclonus0.013% in 202519801990200020102020

Fractional works of Glycogen Storage Diseases and Myoclonus over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Glycogen Storage Diseases and Myoclonus10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Glycogen Storage Diseases and Myoclonus. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.